Spanish Consensus Guidelines on prophylaxis with bypassing agents in patients with haemophilia and inhibitors

Autor: Lopez-Fernandez, MF, Roca, CA, Alvarez-Roman, MT, Hirnyk, MIC, Mingot-Castellanos, ME, Jimenez-Yuste, V, Haro, ARC, Perez-Garrido, R, Balbas, CS

Publikováno v: THROMBOSIS AND HAEMOSTASIS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Prophylaxis with the blood clotting factor, factor VIII (FVIII) is ineffective for individuals with haemophilia A and high-titre inhibitors to FVIII. Prophylaxis with the FVIII bypassing agents activated prothrombin complex concentrates (aPCC; FEIBA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::8902bcb2fc6fe202d7bd03e28b273217
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9087